Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone

Bioconjugate Chemistry

Volumn 20, Issue 10, 2009, Pages 1950-1957

  Phillips, Joy A ^a   Morgan, Edward L ^a   Dong, Yuxiang ^b   Cole, Garry T ^c   McMahan, Cody ^c   Hung, Chiung Yu ^c   Sanderson, Sam D ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; ANTIBODIES; BODY FLUIDS; MAMMALS; PEPTIDES;

ABSORBANCES; AMIDE BOND; ARYLHYDRAZONE; BIOACTIVE PEPTIDES; BOVINE SERUM ALBUMINS; N TERMINUS; OVALBUMINS; SINGLE-STEP; SITE-SPECIFIC; SPECIFIC CONJUGATIONS;

VACCINES;

BOVINE SERUM ALBUMIN; COMPLEMENT COMPONENT C5A RECEPTOR; FUNGUS VACCINE; HYDRAZONE DERIVATIVE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 6; OVALBUMIN; PEPTIDE DERIVATIVE; PROTEIN EP67; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; CHEMICAL BOND; COCCIDIOIDES; CONJUGATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FUNGUS SPORE; INFLUENZA VIRUS; MOUSE; NONHUMAN; VACCINATION; VIRION;

BOVINAE; COCCIDIOIDES; MUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; COCCIDIOIDES; FEMALE; HUMANS; HYDRAZONES; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; NIACINAMIDE; OLIGOPEPTIDES; ORTHOMYXOVIRIDAE; OVALBUMIN; SERUM ALBUMIN, BOVINE; SPORES, FUNGAL; SUCCINIMIDES; VACCINATION; VACCINES;

EID: 70350342886     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9002794     Document Type: Article

References (16)

1. Schwartz, D. A., Abrams, M. J., Hauser, M. M., Gaul, F. E., Larsen, S. K., Rauh, D., and Zubieta, J. A. (1991) Preparation of hydrazino-modified proteins and their use for the synthesis of technietium-99m protein conjugates. Bioconjugate Chem. 2, 333-338.
2. Miranda-Olvera, A. D., Ferro-Flores, G., Pedraza-Lopez, M., Arteaga de Murphy, C., and De Leon-Rodriguez, L. M. (2007) Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer. Bioconjugate Chem. 18, 1560-1567. (Pubitemid 47464065)
3. Taylor, S. M., Sherman, S. A., Kirnarsky, L., and Sanderson, S. D. (2001) Development of response-selective agonists of human C5a anaphylatoxin: conformational, biological, and therapeutic considerations. Curr. Med. Chem. 8, 675-684. (Pubitemid 32409799)
4. Short, A. J., Paczkowski, N. J., Vogen, S. M., Sanderson, S. D., and Taylor, S. M. (1999) Response-selective C5a agonists: differential effects on neutropenia and hypertension in the rat. Br. J. Pharmacol. 128, 511-514. (Pubitemid 29504737)
5. Vogen, S. M., Paczkowski, N. J., Kirnarsky, L., Short, A., Whitmore, J. B., Sherman, S. A., Taylor, S. M., and Sanderson, S. D. (2001) Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation. Int. Immunopharmacol. 1, 2151-2162. (Pubitemid 32973707)
6. Hegde, G. V., Meyers-Clark, E., Joshi, S. S., and Sanderson, S. D. (2008) A conformationally-biased, response-selective agonist of C5a acts as a molecular adjuvant by modulating antigen processing and presentation activities of human dendritic cells. Int. Immunopharmacol. 8, 819-827.
7. Bao, T., Bai, Y., Chang, Y., Chen, S., and Li, Z. (2007) Technetium-99m-labeling and synthesis of thydmidine analogs: potential candidates for tumor imaging. Bioorg. Med. Chem. Lett. 17, 3440-3444. (Pubitemid 46819015)
8. Xue, J., Chen, X., Selby, D., Hung, C.-Y., Yu, J.-J., and Cole, G. T. (2009) A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect. Immun. 77, in press.
9. Morgan, E. L., Sanderson, S. D., Scholz, W., Noonan, D. J., Weigle, W. O., and Hugli, T. E. (1992) Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148, 3937-3942.
10. Tempero, R. M., Hollingsworth, M. A., Burdick, M. D., Finch, A. M., Taylor, S. M., Vogen, S. M., Morgan, E. L., and Sanderson, S. D. (1997) Molecular adjuvant effects of a conformationaly biased agonist of human C5a anaphylatoxin. J. Immunol. 158, 1377-1382.
11. Sarin, V. K., Kent, S. B. H., Tam, J. P., and Merrifield, R. B. (1981) Quantitative monitoring of solid phase peptide synthesis by the ninhydrin reaction. Anal. Biochem. 117, 147-157.
12. Ulrich, J. T., Cieplak, W., Paczkowski, N. J., Taylor, S. M., and Sanderson, S. D. (2000) Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant. J. Immunol. 164, 5492-5498. (Pubitemid 30305234)
13. Buchner, R., Vogen, S. M., Sanderson, S. D., Ye, R. D., and Morgan, E. L. (1997) Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide κR(33-52) derived from the predicted amino-terminal region of the human kappa receptor. J. Immunol. 158, 1670-1680. (Pubitemid 127469521)
14. Sanderson, S. D., Cheruku, S. R., Padmanilayam, M. P., Vennerstrom, J. L., Thiele, G. M., Palmatier, M. I., and Bevins, R, A. (2003) Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant. Int. Immunopharmacol. 3, 137-146.
15. Floreani, A. A., Gunselman, S. J., Heires, A. J., Hauke, R. J., Tarantolo, S., and Jackson, J. D. (2007) Novel C5a agonist-based dendritic cell vaccine in a murine model of melanoma. Cell Cycle 6, 2835-2839. (Pubitemid 350277177)
16. Duryee, M. J., Bevins, R. A., Reichel, R. M., Murray, J. E., Dong, T., Thiele, G. M., and Sanderson, S. D. (2009) Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines. Vaccine 27, 2981-2988.